Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class i variation

Leukemia

Volumn 27, Issue 1, 2013, Pages 255-258

  Di Bernardo, M C ^a   Broderick, P ^a   Harris, S ^a   Dyer, M J S ^b   Matutes, E ^a   Dearden, C ^a   Catovsky, D ^a   Houlston, R S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ADAPTIVE IMMUNITY; ALLELE; B LYMPHOCYTE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LETTER; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENES, MHC CLASS I; GENOME-WIDE ASSOCIATION STUDY; HLA-A2 ANTIGEN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84873569403     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.173     Document Type: Letter

References (15)

1. Sellick GS, Catovsky D, Houlston RS. Familial chronic lymphocytic leukemia. Semin Oncol 2006; 33: 195-201.
2. Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 2008; 82: 48-56.
3. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008; 40: 1204-1210.
4. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS et al. Genomewide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2011; 117: 1911-1916.
5. Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ et al. Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL. Blood 2008; 111: 5691-5693.
6. Damle RN, Calissano C, Chiorazzi N. Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells. Best Pract Res Clin Haematol Mar 23: 33-45.
7. Zhang SY, Gu HX, Li D, Yang SF, Zhong ZH, Li XK et al. Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes. Jpn J Infect Dis 2006; 59: 353-357.
8. Souza CF, Noguti EN, Visentainer JE, Cardoso RF, Petzl-Erler ML, Tsuneto LT. HLA and MICA genes in patients with tuberculosis in Brazil. Tissue Antigens 2012; 79: 58-63.
9. Bergamaschi L, Leone MA, Fasano ME, Guerini FR, Ferrante D, Bolognesi E et al. HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun 2011; 11: 173-180.
10. Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV\+ Hodgkin lymphoma. Blood 2007; 110: 3310-3315.
11. Urayama KY, Jarrett RF, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 2012; 104: 240-253.
12. Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010; 42: 599-603.
13. Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 2009; 41: 873-875.
14. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N et al. Genomewide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010; 42: 661-664.
15. Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 2010; 42: 1126-1130.